Moorfields Eye Hospital NHS Foundation Trust
Moorfields Eye Hospital NHS Foundation Trust
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Parasitic Ulcer Treatment Trial | Acanthamoeba keratitis, Infections, amebiasis, corneal disorder, corneal ulcer, eye disorder, eye infectious disorder, keratitis, parasitic eye infection, parasitic infectious disease, protozoa infectious disease | Recruiting | Phase 3 | 2026-10-01 | NCT06213649 | |
| Metagenomics for Ocular Inflammation | Infections, eye disorder, uveal disorder, uveitis | Recruiting | Not stated | 2026-07-21 | NCT06974162 | |
| Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool | CNS demyelinating autoimmune disease, Disease Attributes, Genetic Risk Score, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, disease susceptibility, eye disorder, immune system disorder, inherited disease susceptibility, lymphatic system disorder, lymphoproliferative syndrome, multiple sclerosis, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis, sarcoidosis | Not yet recruiting | Not stated | 2026-07-15 | NCT07704294 | |
| Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial | anterior uveitis, eye disorder, intermediate uveitis, panuveitis, uveal disorder, uveitis | Not yet recruiting | Phase 4 | 2026-07-13 | NCT07699107 | |
| Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) | CNS demyelinating autoimmune disease, Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, nervous system disorder, optic nerve disorder, optic neuritis, vision disorder | Recruiting | Phase 2 | 2026-03-11 | NCT02521311 | |
| Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 2 | 2026-01-07 | NCT05418010 | |
| UK Imaging Diabetes Study Seeing Diabetes Clearly | Type2 Diabetes | Recruiting | Not stated | 2025-12-05 | NCT05057403 | |
| Usability User Testing of the Easy-EyeFM AI Platform | Ocular Diseases | Recruiting | Not applicable | 2025-08-15 | NCT06834906 | |
| Development of Novel Clinical Endpoints in Intermediate AMD | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Not stated | 2025-01-16 | NCT03349801 | |
| Retinal Pigment Epithelium Safety Study for Patients in B4711001 | age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Not stated | 2024-11-22 | NCT03102138 | |
| Investigating Epstein-Barr Virus Associated Conjunctivitis | Conjunctival Diseases, DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, conjunctivitis, eye disorder, viral infectious disease | Enrolling by invitation | Not stated | 2024-11-14 | NCT06689397 |